BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Merz Pharma GmbH & Co. KGaA 

Eckenheimer Landstraße 100-104

Frankfurt am Main    D-60318  Germany
Phone: 49-69-15-03-1 Fax: 49-0-69-15-03-200


SEARCH JOBS




Industry
Pharmaceutical


Collaborations

Forest Laboratories, Inc.  Licensing agreement for the development and marketing in the U.S. of memantine for the treatment of Alzheimer's Disease and neuropathic pain. Licensing agreement for neramexane, a patented novel NMDA receptor antagonist that is being investigated for a broad range of possible indications related central nervous system disorders.





 Company News
Forest Laboratories, Inc. (FRX) Files Lawsuit Against Several Companies For Infringement Of NAMENDA XR ® Patents 2/3/2014 7:17:47 AM
Forest Laboratories, Inc. (FRX), Merz Pharma GmbH & Co. KGaA Settle Patent Dispute Over Namenda 7/23/2010 7:16:14 AM
Neurobiological Technologies, Inc. (NTII) Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine 2/3/2009 8:26:16 AM
Forest Laboratories, Inc. (FRX) and Merz Pharma GmbH & Co. KGaA File Additional Lawsuit Against Several Companies for Patent Infringement 1/25/2008 11:20:45 AM
Forest Laboratories, Inc. (FRX) and Merz GmbH & Co. KGaA File Lawsuits Against Several Companies for Patent Infringement 1/11/2008 7:54:30 AM
Bernhard Scheuble Appointed As CEO Of The MERZ Group 9/27/2006 1:51:01 PM
Neurobiological Technologies, Inc. (NTII) Receives $1.1 Million Royalty Payment Related To Memantine10/19/2005 5:10:41 PM
Forest Laboratories, Inc. (FRX) Announces That Neramexane Did Not Demonstrate Statistical Significance In Recently Completed Phase III Trial In Patients With Moderate To Severe Alzheimer's Disease10/19/2005 5:10:29 PM
Merz GmbH & Co. KGaA Release: Memantine Captures US Market 10/19/2005 5:10:11 PM
Neurobiological Technologies, Inc. (NTII) Receives $2.25 Million Payment Related To Alzheimer's Drug10/19/2005 5:09:55 PM